Главная страница

Клинические рекомендации гемодиализ. Клинич.-рекоменд._гемодиализ18.03.16_-последняя-версия. Клинические рекомендации Лечение пациентов с хронической болезнью почек 5 стадии (хбп 5)


Скачать 0.75 Mb.
НазваниеКлинические рекомендации Лечение пациентов с хронической болезнью почек 5 стадии (хбп 5)
АнкорКлинические рекомендации гемодиализ
Дата28.01.2020
Размер0.75 Mb.
Формат файлаpdf
Имя файлаКлинич.-рекоменд._гемодиализ18.03.16_-последняя-версия.pdf
ТипДокументы
#106139
страница5 из 5
1   2   3   4   5
Список литературы.
1. Бикбов Б.Т., Томилина Н.А. Заместительная терапия больных с хронической почечной недостаточностью в Российской Федерации в 1998–2011 гг. (Отчет по
данным Российского регистра заместительной почечной терапии). Нефрология и диализ. 2014; 16 (1)
2. Готье С.В., Мойсюк Я.Г., Хомяков С.М. Донорство и трансплантация органов в
Российской Федерации. VI сообщение регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов. 2014; 16 (2)
3. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604–612 4. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic
Kidney Disease. Kidney Int. 2013; 3 (1)
5. European Best Practice Guidelines for Haemodialysis (Part 1)
Nephrol Dial Transplant
(2002) 17 [Suppl 7]
6.
European best practice guidelines on haemodialysis (Part 2)
Nephrol Dial Transplant (2007)
22 [Suppl 2]:
7. National Kidney Foundation
KDOQI
Clinical Practice Guidelines for Hemodialysis
Adequacy, Update 2006 8. National Kidney Foundation
KDOQI
Clinical Practice Guidelines for Vascular Access,
Update 2006 9.
Locatelli F
,
Martin-Malo A
,
Hannedouche T
, et al. Effect of membrane permeability on survival of hemodialysis patients.
J Am Soc Nephrol.
2009;20(3):645-654 10.
Grooteman MP
, van den Dorpel MA
,
Bots ML
, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes.
J Am Soc Nephrol.
2012;23(6):1087-1096 11.
Ok E
,
Asci G
,
Toz H
, et al. Mortality and cardiovascular events in online haemodiafiltration
(OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study.
Nephrol Dial Transplant.
2013;28(1):192-202 12. Maduell F,
Moreso F
,
Pons M
, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.
J Am Soc Nephrol.
2013;24(3):487-
497.
13. Tattersall J et EUDIAL, Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant. 2013 ;28(3):542-550 14. Davenport A. Optimization of heparin anticoagulation for hemodialysis. Hemodial Int
2011;15 (suppl 1):43-48 15. Fischer KG. Essentials of anticoagulation in hemodialysis.Hemodial Int 2007;11:178-189 16. Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009; 24(5):1574-1579 17. E.Movilli, P.Gaggia, R.Zubani et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. Nephrol Dial Transplant. 2007; 22:
3547–3552 18.
Dialysate for hemodialysis ANSI/AAMI RD52:2004 19. Смирнов А.В., Нестерова О.Б., Суглобова Е.Д. с соавт. Клинико-лабораторная оценка эффективности лечения больных с терминальной стадией почечной недостаточности с использованием хронического гемодиализа и ацидосукцината. Тер Арх. 2013; 85 (1):
69-75 20.
Daugirdas JT
. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error.
J Am Soc Nephrol.
1993;4(5):1205-1213.
21.
Daugirdas JT
. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn.
Adv
Ren Replace Ther.
1995;2(4):295-304.
22. Gotch
FA
. Evolution of the single-pool urea kinetic model.
Semin Dial.
2001;14(4):252-256.
23.
National Kidney Foundation
KDOQI Clinical Practice Guidelines for Cardiovascular
Disease in Dialysis Patients 2005

24. European Best Practice Guidelines for the Management of Anaemia in Patients with
Chronic Renal Failure
Nephrol Dial Transplant 1999;14 [Suppl 5]
25. Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure
Nephrol Dial Transplant 2004;19 [Suppl 2]
26.
National Kidney Foundation
KDOQI Clinical Practice Guideline and Clinical Practice
Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin
Target
27. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney Int
Supplements 2012; Vol 2, Issue 4, August (2)
28.
National Kidney Foundation
KDOQI Clinical Practice Guidelines for Bone Metabolism and
Disease in Chronic Kidney Disease 2003 29.
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and
Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD) Kidney Int
2009 Vol 76, Suppl 113 30.
National Kidney Foundation
KDOQI
Nutrition Guidelines American Journal of Kidney
Diseases,Vol 35, No 6, Suppl 2, 2000: S1-S3 31.
National Kidney Foundation
KDOQI Clinical Practice Guidelines for Cardiovascular
Disease in Dialysis Patients 2005 32.
Charlson ME
,
Pompei P
,
Ales KL
,
MacKenzie CR
. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
J Chronic
Dis.
1987;40(5):373-383.
33. Floege J, Kim J, Ireland E et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26:1948–
1955 34. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648-658.
35. Robinson BM, Tong L, Zhang J et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int
2012;82(5):570-580
1   2   3   4   5


написать администратору сайта